Key result
Younger human CD34+ cells limit post-MI remodeling and preserve cardiac function in mice versus older cells.
Why the study?
Less is known about how aging affects human bone marrow cells and their ability to regulate repair processes following myocardial infarction.
Does reconstitution with younger human CD34+ cells improve cardiac repair and survival post-MI compared to older cells in a humanized mouse model?
Does reconstitution with younger human CD34+ cells improve cardiac repair and survival post-MI compared to older cells in a humanized mouse model?
Aging impairs the ability of human bone marrow CD34+ cells to orchestrate cardiac repair and limit ventricular remodeling following myocardial infarction in a humanized mouse model.
Answers are grounded in this paper and cite their sources.
Aging impairs human CD34+ cell reparative capacity post-MI in mice; leaves open translation to age-selected cell therapies in patients.
Ventricular remodeling following myocardial infarction (MI) is a major cause of heart failure, a condition prevalent in older individuals. Following MI, immune cells are mobilized to the myocardium from peripheral lymphoid organs and play an active role in orchestrating repair. While the effect of aging on mouse bone marrow (BM) has been studied, less is known about how aging affects human BM cells and their ability to regulate repair processes. In this study, we investigate the effect aging has on human BM cell responses post‐MI using a humanized chimeric mouse model. BM samples were collected from middle aged (mean age 56.4 ± 0.97) and old (mean age 72.7 ± 0.59) patients undergoing cardiac surgery, CD34 +/− cells were isolated, and NOD‐scid‐IL2rγ null (NSG) mice were reconstituted. Three months following reconstitution, the animals were examined at baseline or subjected to coronary artery ligation (MI). Younger patient cells exhibited greater repopulation capacity in the BM, blood, and spleen as well as greater lymphoid cell production. Following MI, CD34 + cell age impacted donor and host cellular responses. Mice reconstituted with younger CD34 + cells exhibited greater human CD45 + recruitment to the heart compared to mice reconstituted with old cells. Increased cellular responses were primarily driven by T‐cell recruitment, and these changes corresponded with greater human IFNy levels and reduced mouse IL‐1β in the heart. Age‐dependent changes in BM function led to significantly lower survival, increased infarct expansion, impaired host cell responses, and reduced function by 4w post‐MI. In contrast, younger CD34 + cells helped to limit remodeling and preserve function post‐MI.
No takes yet. Share an insight, caveat, or question.
Marvasti et al. (2021) studied Myocardial infarction. Younger human CD34+ bone marrow cells vs. Old human CD34+ bone marrow cells was evaluated on Survival, infarct expansion, host cell responses, and cardiac function. Younger human CD34+ bone marrow cells limited remodeling and preserved cardiac function post-MI in humanized mice, whereas older cells led to lower survival and increased infarct expansion.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: